Showing 2471-2480 of 7016 results for "".
Artificial Intelligence in Clinical Neurology: Opportunities, Limitations, and the Path Forward
https://reachmd.com/diseases-diagnoses/imaging-testing/artificial-intelligence-in-clinical-neurology-opportunities-limitations-and-the-path-forward/56386/Artificial intelligence is revolutionizing clinical neuroimaging by enhancing how neurologic conditions are diagnosed, prioritized, and managed, but its challenges must be addressed to ensure safe and fair use across diverse patient populations.Aesthetic Laser Innovators Discuss What Is Next
https://reachmd.com/programs/modern-aesthetics-focus-on-energy-based-devices/aesthetic-laser-innovators-discuss-what-is-next/56627/A roundtable discussion with Jill S. Waibel, MD, FACS, FAAD; R. Rox Anderson, MD, FAAD; Roy Geronemus, MD; and E. Victor Ross, MD, FAADHair Restoration for Generation X
https://reachmd.com/topics/injectables/hair-restoration-for-generation-x/48725/A Conversation With Suneel Chilukuri, MD, FAAD, FACMSBoard Forum: Best Solutions for Practice
https://reachmd.com/topics/practice-development/board-forum-best-solutions-for-practice/35171/Precision Medicine for AD
https://reachmd.com/columns/atopic-dermatitis-essentials/precision-medicine-for-ad/54826/A Q & A with Derek MaetzoldThe Future of Beauty is Stacked, Preventive, and Driven by Technology
https://reachmd.com/ma-issues-index/jan-feb-2026-issue/the-future-of-beauty-is-stacked-preventive-and-driven-by-technology/54430/The FDA Expands Indication for Baloxavir Marboxil to Include Post-Exposure Influenza Prevention
https://reachmd.com/programs/the-drug-report/the-fda-expands-indication-for-baloxavir-marboxil-to-include-post-exposure-influenza-prevention/12043/Previously used for acute uncomplicated influenza, baloxavir marboxil has been approved by the FDA for post-exposure influenza prevention.FDA Approves Remdesivir, the First COVID-19 Treatment
https://reachmd.com/programs/the-drug-report/fda-approves-remdesivir-the-first-covid-19-treatment/11970/Learn about Remdesivir, the first FDA-approved treatment for the SARS-CoV-2 virus.Novel Therapeutic & Prevention Approaches to the Novel Coronavirus
https://reachmd.com/programs/the-drug-report/novel-therapeutic-prevention-approaches-to-the-novel-coronavirus/11441/Researchers all over the world are trying many novel approaches to conquer the novel coronavirus. Here are a few of them.Therapies & Vaccines on the Horizon for COVID-19
https://reachmd.com/programs/the-drug-report/therapies-vaccines-on-the-horizon-for-covid-19/11288/After much research activity has been devoted to finding a vaccine and cure for COVID-19, could there finally be hope amid this global pandemic?